Yes, it is bleeding obvious that all is not well with US launch after we were made to believe that this launch will be the saviour of Cellmid. Otherwise the Q2 would contain a statement on the volumes of sale or revenue. Just a statement on the sales volume, revenue and cost of sales will be enough Taurean7.
Looking forward the half yearly report including US results.